Lianne Krab - Publications

Erasmus Medical Center Rotterdam, Rotterdam, Netherlands 
learning and memory

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Rietman AB, van der Vaart T, Plasschaert E, Nicholson BA, Oostenbrink R, Krab LC, Descheemaeker MJ, Wit MY, Moll HA, Legius E, Nijs PFA. Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 29243874 DOI: 10.1002/ajmg.b.32612  0.48
2012 van Beveren NJ, Krab LC, Swagemakers S, Buitendijk G, Buitendijk GH, Boot E, van der Spek P, Elgersma Y, van Amelsvoort TA. Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome. Plos One. 7: e33473. PMID 22457764 DOI: 10.1371/journal.pone.0033473  0.92
2012 van Beveren NJ, Buitendijk GH, Swagemakers S, Krab LC, Röder C, de Haan L, van der Spek P, Elgersma Y. Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients. Plos One. 7: e32618. PMID 22393424 DOI: 10.1371/journal.pone.0032618  0.92
2011 Krab LC, de Goede-Bolder A, Aarsen FK, Moll HA, De Zeeuw CI, Elgersma Y, van der Geest JN. Motor learning in children with neurofibromatosis type I. Cerebellum (London, England). 10: 14-21. PMID 20927664 DOI: 10.1007/s12311-010-0217-2  0.92
2009 Krab LC, Oostenbrink R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. The Journal of Pediatrics. 154: 420-5, 425.e1. PMID 18950800 DOI: 10.1016/j.jpeds.2008.08.045  0.92
2009 Oostenbrink R, Krab LC, de Goede-Bolder A, Moll HA. Reply Journal of Pediatrics. 155: 454. DOI: 10.1016/j.jpeds.2009.06.022  0.92
2008 Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, Elgersma Y. Impact of neurofibromatosis type 1 on school performance. Journal of Child Neurology. 23: 1002-10. PMID 18827266 DOI: 10.1177/0883073808316366  0.92
2008 Krab LC, Goorden SM, Elgersma Y. Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. Trends in Genetics : Tig. 24: 498-510. PMID 18774199 DOI: 10.1016/j.tig.2008.07.005  0.92
2008 Krab LC, de Goede-Bolder A, Aarsen FK, Pluijm SM, Bouman MJ, van der Geest JN, Lequin M, Catsman CE, Arts WF, Kushner SA, Silva AJ, de Zeeuw CI, Moll HA, Elgersma Y. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. Jama. 300: 287-94. PMID 18632543 DOI: 10.1001/jama.300.3.287  0.92
2008 van Engelen SJ, Krab LC, Moll HA, de Goede-Bolder A, Pluijm SM, Catsman-Berrevoets CE, Elgersma Y, Lequin MH. Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. Ajnr. American Journal of Neuroradiology. 29: 816-22. PMID 18339726 DOI: 10.3174/ajnr.A0921  0.92
2008 Shilyansky C, Li W, Acosta M, Elgersma Y, Hannan F, Hardt M, Hunter-Schaedle K, Krab LC, Legius E, Wiltgen B, J Silva A. Molecular and cellular mechanisms of learning disabilities: A focus on neurofibromatosis type I Animal and Translational Models For Cns Drug Discovery. 2: 77-92. DOI: 10.1016/B978-0-12-373861-5.00015-1  0.92
2008 Elgersma Y, Krab LC, Moll HA. Statin therapy and cognitive deficits associated with neurofibromatosis type 1: Reply Jama - Journal of the American Medical Association. 300: 2369-2370. DOI: 10.1001/jama.2008.688  0.92
Show low-probability matches.